Self-sampling of vaginal fluid and high-risk human papillomavirus testing in women aged 50 years or older not attending Papanicolaou smear screening

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 119, Issue 2, 2012, Pages 245-248

  Lindell, M ^a   Sanner, K ^a   Wikstrom I ^a   Wilander, E ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cervix; cytology; human papillomavirus test; screening; self sampling at home

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; COHORT ANALYSIS; COLPOSCOPY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PAPILLOMA VIRUS; PATIENT REFERRAL; PRIORITY JOURNAL; SCREENING TEST; UTERINE CERVIX CARCINOMA IN SITU; VAGINA DISCHARGE; WOMEN'S HEALTH;

AGED; BODY FLUIDS; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; SELF-EXAMINATION; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; UTERINE CERVICAL NEOPLASMS; VAGINA; VAGINAL SMEARS;

EID: 83655201291     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2011.03147.x     Document Type: Article

References (22)

1. Andrae B, Kemetli L, Sparén P, Silfverdal L, Strander B, Ryd W, et al., Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden. J Natl Cancer Inst 2008; 100: 605-6.
2. Bos A, Rebolj M, Habbema JD, van Ballegooijen M,. Nonattendance is still the main limitation for the effectiveness of screening for cervical cancer in the Netherlands. Int J Cancer 2006; 119: 2372-5. (Pubitemid 44546958)
3. Lindqvist PG, Hellsten C, Rippe A,. Screening history of women in Malmö with invasive cervical cancer. Eur J Obstet Gynecol Reprod Biol 2008; 137: 77-83. (Pubitemid 351625427)
4. Wright TC Jr, Schiffman M, Solomon D, Cox JT, Garcia F, Goldie S, et al., Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet Gynecol 2004; 103: 304-9.
5. Meijer CJ, Berkhof J, Castle PE, Hesselink AT, Franco EL, Ronco G, et al., Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older. Int J Cancer 2009; 124: 516-20.
6. Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, et al., Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasias: a randomised controlled trial. Lancet Oncol 2010; 11: 249-57.
7. Anttila A, Kotaniemi-Talonen L, Leinonen M, Hakama M, Laurila P, Tarkkanen J, et al., Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme. BMJ 2010; 340: 1-8.
8. Woodman CB, Collins S, Winter H, Bailey A, Ellis J, Prior P, et al., Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 2001; 357: 1831-6. (Pubitemid 32539115)
9. Rodríguez AC, Schiffman M, Herrero R, Wacholder S, Hildesheim A, Castle PE, et al., Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections. J Natl Cancer Inst 2008; 100: 513-7.
10. Plummer M, Schiffman M, Castle PE, Maucort-Boulch D, Wheeler CM,; ALTS Group. A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion. J Infect Dis 2007; 195: 1582-9. (Pubitemid 46799215)
11. Stenvall H, Wikström I, Wilander E,. Human papilloma virus testing of vaginal smear obtained with a novel self-sampling device. Acta Derm Venereol 2006; 86: 465-7. (Pubitemid 44450114)
12. Sanner K, Wikström I, Strand A, Lindell M, Wilander E,. Self-sampling of the vaginal fluid at home combined with high-risk HPV testing. Br J Cancer 2009; 101: 871-4.
13. Gustafsson L, Pontén J, Bergström R, Adami HO,. International incidence rates of invasive cervical cancer before cytological screening. Int J Cancer 1997; 71: 159-65. (Pubitemid 27252984)
14. Bergström R, Sparén P, Adami HO,. Trends in cancer of the cervix uteri in Sweden following cytological screening. Br J Cancer 1999; 81: 159-66. (Pubitemid 29415507)
15. Gyllensten U, Lindell M, Gustafsson I, Wilander E,. HPV test shows low sensitivity of Pap screen in older women. Lancet Oncol 2010; 11: 509-10.
16. Gustafsson L, Sparén P, Gustafsson M, Pettersson B, Wilander E, Bergstrom R, et al., Low efficiency of cytological screening for cancer in situ of the cervix in older women. Int J Cancer 1995; 63: 804-9.
17. Leinonen M, Nieminen P, Kotaniemi-Talonen L, Malila N, Tarkkanen J, Laurila P, et al., Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting. J Natl Cancer Inst 2009; 101: 1612-23.
18. Eaker S, Adami H-O, Granath F, Wilander E, Sparén P,. A large population-based randomized controlled trial to increase attendance at screening for cervical cancer. Cancer Epidemiol Biomarkers Prev 2004; 13: 346-54. (Pubitemid 38737457)
19. Gök M, Heideman DA, van Kemenade FJ, Berkhof J, Rozendaal L, Spruyt JW, et al., HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study. BMJ 2010; 11: 340: c1040.
20. Bhatla N, Dar L, Patro AR, Kumar P, Kriplani A, Gulati A, et al., Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries? Cancer Epidemiol 2009; 33: 446-50.
21. Tamalet C, Richet H, Carcopino X, Henry M, Leretraite L, Heid P, et al., Testing for human papillomavirus and measurement of viral load of HPV 16 and 18 in self-collected vaginal swabs of women who do not undergo cervical cytological screening in Southern France. J Med Virol 2010; 82: 1431-7.
22. Wikström I, Stenvall H, Wilander E,. Low prevalence of high-risk HPV in older women not attending organized cytological screening: a pilot study. Acta Derm Venereol 2007; 87: 554-5. (Pubitemid 351373409)